938 results on '"Lazaros, George"'
Search Results
2. Coronary artery thromboembolism as a cause of myocardial infarction with non-obstructive coronary arteries (MINOCA)
3. Impact of drinking water hardness on carotid atherosclerosis and arterial stiffness: Insights from the “Corinthia” study
4. D-dimer as a diagnostic and prognostic plasma biomarker in patients with a first episode of acute pericarditis
5. Chronic Pericardial Effusion: Causes and Management
6. Cardiomyopathies in children: An overview
7. Acute Pericarditis: Update
8. The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness
9. Myocarditis
10. Novel Treatments in Refractory Recurrent Pericarditis.
11. The Association of Depression With QT Duration: A Comparison Between Individuals Younger or Older Than 65 Years
12. The impact of sleeping duration on atherosclerosis in the community: insights from the Corinthia study
13. The Torino Pericarditis Score: a new-risk stratification tool to predict complicated pericarditis
14. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis
15. Large pericardial effusion in a woman in the second trimester of pregnancy: a case report
16. Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy
17. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions
18. Acute Coronary Syndromes in Women: A Narrative Review of Sex-Specific Characteristics
19. The tale of refractory recurrent pericarditis
20. Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes
21. New Approaches to Management of Pericardial Effusions
22. The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study
23. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis.
24. The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
25. Ikaria Study, Greece
26. Left ventricular non-compaction in patients with β-thalassemia: structural remodeling or cardiomyopathy?
27. Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis
28. Inflammatory Mediators of Endothelial Dysfunction
29. Cardiac magnetic resonance imaging of pericardial diseases: a comprehensive guide
30. Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines
31. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality
32. Risk stratification in hypertrophic cardiomyopathy
33. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
34. Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term
35. The Impact of High Protein Diets on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies
36. Interleukin-1 blockade for recurrent pericarditis: Insights from the real-world experience
37. The Role of Nutrition in Cardiovascular Disease: Current Concepts and Trends
38. Impact of Evolution of Self-Expandable Aortic Valve Design: Peri-Operative and Short-Term Outcomes
39. Cholesterol Pericarditis following COVID-19 vaccination
40. Untying the Gordian knot of pericardial diseases: A pragmatic approach
41. Environment and cardiovascular disease: rationale of the Corinthia study
42. One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.
43. Role of genetic testing in cardiomyopathies: Α primer for cardiologists
44. Is pericardial effusion a negative prognostic marker? Meta-analysis of outcomes of pericardial effusion
45. Asymmetric dimethylarginine as a biomarker in coronary artery disease
46. The Association of Depression With QT Duration: A Comparison Between Individuals Younger or Older Than 65 Years
47. Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease
48. Extracellular Matrix Remodeling Biomarkers in Coronary Artery Disease
49. Danon Cardiomyopathy
50. Recurrent pericarditis: moving from the middle ages to renaissance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.